Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Total Current Liabilities (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Total Current Liabilities for 5 consecutive years, with $17.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 41.23% to $17.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.6 million, a 41.23% increase, with the full-year FY2024 number at $15.2 million, down 21.66% from a year prior.
  • Total Current Liabilities was $17.6 million for Q3 2025 at Werewolf Therapeutics, up from $15.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $30.4 million in Q2 2022 to a low of $5.4 million in Q1 2021.
  • A 5-year average of $15.8 million and a median of $15.0 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 312.05% in 2022, then tumbled 50.59% in 2023.
  • Werewolf Therapeutics' Total Current Liabilities stood at $11.9 million in 2021, then surged by 102.03% to $24.0 million in 2022, then dropped by 19.22% to $19.4 million in 2023, then decreased by 21.66% to $15.2 million in 2024, then rose by 15.96% to $17.6 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Total Current Liabilities are $17.6 million (Q3 2025), $15.2 million (Q2 2025), and $11.7 million (Q1 2025).